Kwality Pharmaceuticals Share Price Gains Over 7% After Q4 FY26 Earnings Results: Net Profit up 74.8% YoY

Written by: Team Angel OneUpdated on: 20 May 2026, 5:41 pm IST
Kwality Pharmaceuticals' Q4 revenue rose 35.8% YoY to ₹158.17 crore; FY26 revenue up 36% YoY to ₹505.94 crore.
Kwality Pharmaceuticals Share Price Gains Over 7%
ShareShare on 1Share on 2Share on 3Share on 4Share on 5

Kwality Pharmaceuticals has announced its consolidated audited results for the quarter and year ending March 31, 2026.  

The company has shown significant growth in both revenue and profit, reflecting its robust performance in the pharmaceutical sector. 

Kwality Pharmaceuticals Q4 FY26 Earnings Results 

For the quarter ending March 31, 2026, Kwality Pharmaceuticals reported a total revenue of ₹158.17 crore, marking a 35.8% increase compared to ₹116.44 crore in the same quarter of the previous year.  

Sequentially, revenue rose by 27.6% from ₹123.97 crore in the December 2025 quarter. 

Net profit for the March 2026 quarter surged by 74.8% year-on-year to ₹25.31 crore, up from ₹14.48 crore in the corresponding quarter last year.  

Compared to the December 2025 quarter, net profit increased by 58.2% from ₹16.00 crore. 

FY26 Annual Performance 

For the financial year ending March 31, 2026, Kwality Pharmaceuticals achieved a total revenue of ₹505.94 crore, representing a 36% year-on-year growth from ₹372.12 crore in FY25.  

The company's net profit for FY26 rose by 69.2% to ₹67.35 crore, compared to ₹39.80 crore in the previous financial year. 

Read More: Zydus Lifesciences Share Price Gains Over 5% After Q4 FY26 Earnings Results: Net Profit up 8.7% YoY! 

Analysis of Revenue and Profit Growth 

The substantial increase in both quarterly and annual revenue and profit figures highlights Kwality Pharmaceuticals' strong market position and effective business strategies.  

The company's ability to achieve significant growth in a competitive market underscores its operational efficiency and strategic planning. 

Kwality Pharmaceuticals Share Price Performance 

As of May 20, 2026, at 11:52 AM, Kwality Pharmaceuticals share price on NSE was trading at ₹2,141.90 up by 7.06% from the previous closing price. 

Conclusion 

Kwality Pharmaceuticals has demonstrated impressive financial growth in Q4 and FY26, with notable increases in both revenue and net profit. The company's performance reflects its strong market presence and successful execution of business strategies. 

Want to track these market movements in Hindi? Visit Angel One News for daily updates and comprehensive share market news in Hindi. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing. 

Published on: May 20, 2026, 12:11 PM IST

Team Angel One

Team Angel One is a group of experienced financial writers that deliver insightful articles on the stock market, IPO, economy, personal finance, commodities and related categories.

Know More

We're Live on WhatsApp! Join our channel for market insights & updates

Open Free Demat Account!

Join our 3.5 Cr+ happy customers

+91
Enjoy Zero Brokerage on Equity Delivery
4.4 Cr+DOWNLOADS
Enjoy ₹0 Account Opening Charges

Get the link to download the App

Get it on Google PlayDownload on the App Store
Open Free Demat Account!
Join our 3.5 Cr+ happy customers